@SPACE ROCKET:$Palantir Technologies Inc.(PLTR)$   I personally do not like PLTR and feel that the run is way overdone. Call me your grapes if you want but that's just my opinion,  so do your own due diligence. Heard enough of the "but PLTR has more room to run, TA suggest otherwise" narrative.  Oh please.  If all stocks follow textbook TA, we'll all be crazy rich. Like it or not, Market Sentiments will screw your portfolios up big time; against your will and against all your textbook TAs, Fibs, ikomuchi clouds and crazy lines. Always do your own due diligence and don't follow the crowd. If it's time to take profits, please do so.  Profits isn't profits till its taken off the table. ​ BACKGROUND Citron Res

@SPACE ROCKET:$MARA DIAGONAL 260320/251219 CALL 29.0/CALL 20.0$ Closing to take profit of $1691 + rolling it to a closer expiry, higher strike, for an extra $500.

@LohYK:$NVO RISK_REVERSAL 250905 PUT 45.0/CALL 46.0$ bought during the bottom. Being a key supplier of obesity drug, i am confident of a rebound. 

@Optionspuppy:$Palantir Technologies Inc.(PLTR)$   Up again once more with the taco of trump  for the 50 coins 

@SPACE ROCKET:$UnitedHealth(UNH)$   🌟✨️ The golden star UNH ✨️🌟  PERFORMANCE AND CONTEXT 1. ​Stock Volatility UNH stock has been experiencing significant volatility. It was down more than 40% year-to-date at one point, trading near multi-year lows.   2. ​Challenges The company has faced several challenges, including a federal investigation into its Medicare billing practices, a change in leadership, and higher-than-expected medical costs, particularly in its Medicare Advantage business. These factors have contributed to investor uncertainty and a decline in the stock price.   3. ​Q2 2025 Earnings UnitedHealth Group's Q2 2025 results showed revenue growth, but net income and earnings per share (EPS) wer